138668-80-1

Usage

Uses

Used in Pharmaceutical Research and Development:
ANTHRANILYL-HIV PROTEASE SUBSTRATE III is used as a research tool for the development and screening of potential HIV protease inhibitors. Its fluorescent properties enable the assessment of inhibitory activity, helping researchers to identify compounds that can effectively suppress the function of HIV protease, a key enzyme in the viral replication process.
Used in HIV Drug Discovery:
In the field of HIV drug discovery, ANTHRANILYL-HIV PROTEASE SUBSTRATE III serves as a valuable assay component for evaluating the potency and selectivity of new antiviral agents. By monitoring the substrate's fluorescence upon cleavage by HIV protease, researchers can determine the effectiveness of candidate drugs in inhibiting the enzyme, thus contributing to the advancement of HIV treatment options.
Used in Mechanistic Studies:
ANTHRANILYL-HIV PROTEASE SUBSTRATE III is also used in mechanistic studies to understand the detailed action of HIV protease and its interaction with potential inhibitors. This knowledge is crucial for the rational design of drugs that can specifically target and inactivate the enzyme, thereby impeding the virus's ability to replicate and spread.
Overall, ANTHRANILYL-HIV PROTEASE SUBSTRATE III is a versatile and indispensable tool in the ongoing battle against HIV, facilitating both the fundamental understanding of the virus's biology and the development of novel therapeutic strategies.